Frequency and risk factors for thromboembolic complications in patients with inflammatory bowel diseases
Lishchinskaya A.A., Knyazev O.V., Kagramanova A.V., Dudina G.A., Sabelnikova E.A., Li I.A., Noskova K.K., Bodunova N.A., Parfenov A.I.
Atherosclerosis and cardiovascular risk in patients with inflammatory bowel disease
Mironova O.I., Isaikina M.A., Khasieva S.A.
Ulcerative colitis. To the 180th anniversary of the description by Karl Rokytansky
Knyazev O.V., Kagramanova A.V., Parfenov A.I.
Low adherence to treatment is a weak link in the problems of ulcerative colitis
Parfenov A.I., Knyazev O.V., Babayan A.F., Kagramanova A.V.
Pharmacotherapy of inflammatory bowel diseases: efficacy performance and safety management
Bakulin I.G., Skalinskaya M.I., Maev I.V., Skazyvaeva E.V., Zhuravleva M.S., Gaikovaya L.B., Bakulina N.V., Ermakov A.I., Alekseenko E.S., Ivanova K.N., Solovev M.V.
Pancreatic diseases and inflammatory bowel diseases: a random or regular combination?
Akhmedov V.A., Gaus O.V.
Biomarkers of inflammatory bowel disease activity
Fadeeva N.A., Korneeva I.A., Knyazev O.V., Parfenov A.I.
Clinical value of antibodies in inflammatory bowel diseases
Aleksandrova E.N., Novikov A.A., Lukina G.V., Parfenov A.I.
Adherence to therapy of patients with inflammatory bowel diseases
Parfenov A.I., Kagramanova A.V., Babayan A.F., Knyazev O.V.
The cardiovascular system in patients with functional and inflammatory bowel diseases
Maev I.V., Kazulin A.N., Andreev D.N.
Loss of response and frequency of adverse events in patients with ulcerative colitis and Crohn’s disease when switching from the original infliximab to its biosimilars
Knyazev O.V., Zvyaglova M.Y., Kagramanova A.V., Li I.A., Sabelnikova E.A., Lishchinskaya A.A., Kulakov D.S., Parfenov A.I.
Ultrasound examination with contrast in the diagnosis of inflammatory bowel disease. The results of the pilot study
Fomin V.V., Ternovoy S.K., Makhov V.M., Isaykina M.A., Dzhenzhera N.A., Turko T.V., Ugryumova L.N., Babenko O.V.
Vedolizumab in patients with inflammatory bowel diseases of in real clinical practice
Shapina M.V., Nanaeva B.A.
Personalized medicine in the treatment of inflammatory bowel diseases
Parfenov A.I., Knyazev O.V., Kagramanova A.V., Fadeeva N.A.
The use of Tofacitinib in the treatment of inflammatory bowel disease
Nasonov E.L., Abdulganieva D.I., Fairushina I.F.
Safety of mesenchymal stromal cell therapy for inflammatory bowel diseases: Results of a 5-year follow-up
Kniazev O.V., Parfenov A.I., Konopliannikov A.G., Ruchkina I.N., Churikova A.A., Bykova S.V., Albulova E.A., Boldyreva O.N., Fadeeva N.A., Lishchinskaia A.A.
Evaluation of efficacy and comparative frequency of adverse events in patients with ulcerative colitis receiving the original infliximab and its biosimilar. One year of observation
Knyazev O.V., Shkurko T.V., Kagramanova A.V., Lishchinskaya A.A., Zvyaglova M.Y., Korneeva I.A., Babayan A.F., Parfenov A.I.
O.V. Knyazev, A.V. Kagramanova, I.A. Korneeva, K.K. Noskova, S.V. Belousov, A.I. Parfenov
Knyazev O.V., Kagramanova A.V., Korneeva I.A., Noskova K.K., Belousov S.V., Parfenov A.I.
Systemic manifestations of inflammatory bowel diseases
Parfenov A.I., Kagramanova A.V., Knyazev O.V.
Frequency of detection of some markers of endothelial dysfunction in patients with inflammatory bowel diseases
Babayeva G.H., Babayev Z.M.
Bronchopulmonary lesions in chronic inflammatory bowel diseases
Mikhaylova Z.F., Lazebnik L.B., Parfenov A.I., Mikhailova Z.F., Lazebnik L.B., Parfenov A.I.
Clostridium difficile in inflammatory bowel disease
Knyazev O.V., Kagramanova A.V., Chernova M.E., Korneeva I.A., Parfenov A.I.
1 - 22 of 22 Items

Search tips:

  • Search terms are case-insensitive
  • Common words are ignored
  • By default only articles containing all terms in the query are returned (i.e., AND is implied)
  • Combine multiple words with OR to find articles containing either term; e.g., education OR research
  • Use parentheses to create more complex queries; e.g., archive ((journal OR conference) NOT theses)
  • Search for an exact phrase by putting it in quotes; e.g., "open access publishing"
  • Exclude a word by prefixing it with - or NOT; e.g. online -politics or online NOT politics
  • Use * in a term as a wildcard to match any sequence of characters; e.g., soci* morality would match documents containing "sociological" or "societal"

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies